Operating expenses and share based payments seem excessive for a company this size. No problems with the R&D expenses. A bit of belt tightening and some sharing of the pain with shareholders wouldn’t go astray.
- Forums
- ASX - By Stock
- CHM
- Ann: Appendix 4E and Preliminary Final Report
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.3¢

Ann: Appendix 4E and Preliminary Final Report, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.747M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.858K | 619.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
66 | 58647032 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 107164382 | 32 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 504907 | 0.004 |
66 | 58761448 | 0.003 |
30 | 25758480 | 0.002 |
19 | 63919001 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 619323 | 3 |
0.004 | 107164382 | 32 |
0.005 | 44186931 | 30 |
0.006 | 20774758 | 20 |
0.007 | 3825018 | 5 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |